Skip to the main content.
Contact Us

At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.


& Live Demos

GABA(A) Receptors and Disease

Dr. Andrew Jenkins Ph.D, Associate Professor, Faculty of Pharmacy & Pharmaceutical Sciences, Emory University School of Medicine

Modeling of Catheter-Associated Infection and Evaluating Antimicrobial Drug Efficacy Using Novel Microfluidic System

Dr. Claudia Vuotto, PhD,Team Leader at Microbial Biofilm Laboratory,Fondazione Santa Lucia IRCCS



A Novel Way to Study hERG Drug Liability

Dr. Khaled Barakat PhD, Assistant Professor, Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta

Sensitivity, Specificity, and Low Cost: Keys for the Clinical Implementation of CTCs Detection

Speakers: María Jose Serrano, PhD, Hospital Universitario Virgen de las Nieves, and Rocio Ramos-Medina, PhD, Hospital General Universitario Gregorio...

Optimizing for High Throughput Information Content from Nav Modulation on the IonFlux Mercury Automated Patch Clamp

Speaker: Péter Lukács, Centre for Agricultural Research, Eötvös Loránd University, Department of Biochemistry

New Research from Flow Assays for Platelet Biology and Vascular Pharmacology Studies

Speaker:Dr. Giordano Pula, PhD, Group Leader for Haemostasis and Thrombosis, University Medical Center Eppendorf, University of Hamburg